Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

NACompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

August 13, 2014

Primary Completion Date

April 27, 2017

Study Completion Date

October 28, 2019

Conditions
Coronary Artery DiseaseCoronary RestenosisCoronary AtherosclerosisCoronary Arteriosclerosis
Interventions
DEVICE

Agent Paclitaxel-coated balloon

After successful pre-dilatation, the index lesion is dilated with a single drug-coated balloon that completely covers the restenotic lesion.

DEVICE

SeQuent® Please Paclitaxel-coated Balloon

After successful pre-dilatation, the index lesion is dilated with a single drug-coated balloon that completely covers the restenotic lesion.

Trial Locations (12)

13353

Charité Universitaetsmedizin Berlin, Berlin

18057

Universitaetsklinikum Rostock, Rostock

34000

Clinique du Millénaire, Montpellier, Montpellier

34090

CHU Montpellier, Hôpital Arnaud de Villeneuve, Montpellier

35392

University Giessen, Giessen

40225

Universitätsklinikum Düsseldorf, Düsseldorf

44093

CHU de Nantes, Hopital Laennec, Nantes

61231

Kerckhoff-Klinik, Bad Nauheim

69007

Centre Hospitalier Saint Joseph Saint Luc de Lyon, Lyon

72764

Klinikum Am Steinenberg, Reutlingen

76000

Clinique Saint Hilaire, Rouen, Rouen

89081

Universitaetsklinikum Ulm, Ulm

All Listed Sponsors
lead

Hemoteq AG

INDUSTRY

NCT02151812 - Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR) | Biotech Hunter | Biotech Hunter